US Patent 11421230 AAV-based treatment of cholesterol-related disorders
Patent 11421230 was granted and assigned to University of Massachusetts on August, 2022 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
June 23, 2020
Date of Patent
August 23, 2022
Patent Applicant
Patent Application Number
16908798
Patent Citations Received
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 11421230 AAV-based treatment of cholesterol-related disorders
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
